If CBD is so good, won’t pure CBD be even better?

Single-molecule CBD will inevitably become a federally approved Big Pharma medicine. Products infused with a crystalline CBDisolate, derived and extensively refined from industrial hemp, are already being marketed.  But single-molecule CBD is less effective therapeutically than whole plant CBD-rich oil extract. Scientific studies have established that synthetic, single-molecule CBD has a very narrow therapeutic window and requires precise, high doses for efficacy, whereas lower dose, whole-plant, CBD-rich treatment regimens are already showing efficacy for many conditions among patients in medical marijuana states. Whether synthesized in a Big Pharma lab or derived from industrial hemp, single-molecule CBD lacks critical secondary cannabinoids and other medicinal compounds found in high-resin cannabis strains. These compounds interact with CBD and THC to enhance their therapeutic benefits. Scientists call this the “entourage effect.” Numerous cannabis compounds have medicinal attributes, but the therapeutic impact of whole plant cannabis is greater than the sum of its parts.

Is there a difference between CBD derived from hemp and CBD derived from marijuana?

Unregulated hemp-derived CBD-infused products of varying quality are also available via dozens of internet storefronts. Many of these products are mislabeled. Compared to whole plant CBD-rich cannabis, industrial hemp grown for fiber or seed is typically low in cannabinoid content. A huge amount of fiber hemp is required to extract a small amount of CBD, thereby raising the risk of contaminants because hemp, a bioaccumulator, draws toxins from the soil. That’s a great feature for restoring a poisoned ecosystem, but it’s not recommended for extracting medicinal oil. Heavily refined CBD paste or terpene-free CBD isolate crystal is poor starter material for formulating CBD-rich oil products. The debate over sourcing CBD from cannabis rather than hemp will soon be moot as plant breeders succeed in developing high-resin CBD-rich cannabis varietals with lass than 0.3% THC, the arbitrarily designated legal limit for hemp.